DelveInsight forecasts a rise in the drug-resistant epilepsy market from 2025 to 2034, driven by higher prevalence, improved diagnosis, treatment advances, aging demographics, increased awareness, and ...

Scientists are moving toward a genetic test that could help thousands of mothers with epilepsy safely take life-saving ...

Please provide your email address to receive an email when new articles are posted on . Allowing clinicians to prescribe a larger supply of antiseizure drugs to veterans with epilepsy improved ...

Epilepsy patients who want to learn how to manage their own unique symptoms can now get individualized information via tablet computer through a research project at the University of Illinois at ...

PENSACOLA, Fla., Feb. 12, 2026 /PRNewswire/ -- Pegasus Laboratories, Inc. (Pegasus), is pleased to announce, under its registered trademark PRN® Pharmacal, that KBroVet® (potassium bromide chewable ...

Patients with treatment-resistant epilepsy often cycle through multiple medications as they seek relief from the seizures that disrupt their lives. Yet in many cases, these drugs offer little benefit, ...

Epilepsy is one of the most common neurological disorders, affecting 3.4 million Americans or 1 in 26 over a lifetime. The hallmark of epilepsy is seizures caused by abnormal bursts of electrical ...

Temporal lobe epilepsy (TLE) is the most common form of focal epilepsy, affecting a significant proportion of patients who develop drug-resistant epilepsy. Surgical interventions, particularly ...